
Viagra alternatives: 1 options compared
Common reasons: cost (generic sildenafil dramatically cheaper), prefer longer-acting option, side-effect intolerance (headache, flushing), or want non-PDE5 alternative.
Last reviewed: June 2026 · Editorial pick at #1 · how we compare
Quick comparison table
| # | Alternative | Best for | Match type |
|---|---|---|---|
| 1 | Cialis tadalafil | Patients wanting longer response window (up to 36 hours) and daily-low-dose option | Same FDA indication |
Each alternative, in depth
#1 — Cialis
★ Editorial picktadalafil
Best for
Patients wanting longer response window (up to 36 hours) and daily-low-dose option
Key difference vs Viagra
Tadalafil instead of sildenafil. Longer half-life. Also approved for BPH (benign prostatic hyperplasia) — useful when both conditions present.
Frequently asked about Viagra alternatives
Quick answers
›Is generic sildenafil the same as Viagra?
Yes. Generic sildenafil contains the same active ingredient at the same doses as Viagra and is FDA-approved. Cost is typically 80-95% lower than brand Viagra. Quality and efficacy are equivalent when sourced from FDA-approved pharmacies.
›Which PDE5 inhibitor has the fewest side effects?
Side-effect profiles overlap substantially across the class. Tadalafil (Cialis) has lower rates of facial flushing than sildenafil in some comparative studies. Avanafil (Stendra) has shorter onset and may reduce some side effects. Individual response varies.
›Are there non-prescription alternatives to Viagra?
No FDA-approved non-prescription PDE5 inhibitors exist in the US. Supplements marketed for erectile function lack rigorous trial evidence and have been associated with adulteration cases (containing unlabeled sildenafil). Discuss any ED concern with a licensed clinician before considering supplements.
Why trust this comparison
Independent
No equity in any telehealth service. We earn affiliate commissions on click-through and never alter rankings for revenue.
Affiliate disclosure →Primary sources
Every clinical claim is cited to FDA labels, peer-reviewed trials with DOI links, or specialty-society guidelines. Never secondary sources.
Editorial methodology →Editorial-revenue separation
Commission rates do not affect ranking, scoring, or inclusion. We publish negative findings on paying affiliate partners.
Editorial policy →